COVID-19 感染またはワクチン接種の3度目の曝露は,T 細胞の反応に差異的な影響を及ぼします
Gift Ahimbisibwe1, David Greenwood1, Katalin Andrea Wilkinson2
1The Francis Crick Institute, NW1 1AT London, UK.
The Journal of infection
|August 23, 2025
まとめ
第3の暴露は,mRNAブースターまたはSARS-CoV-2感染であっても,同様の抗体保護を生成します. しかし,暴露経路は細胞の免疫反応とサイトカインプロフィールに影響し,長期的な免疫に影響します.
科学分野:
- 免疫学
- ウイルス学
- ワクチン学
背景:
- SARS-CoV-2の2回接種により,2021年のCOVID-19の重症度が著しく低下しました.
- 制限されたプライムブーストスケジュールと緩和された制限は,一般的な第三の暴露として感染をもたらしました.
- 異なる第三者被曝に対する免疫反応を理解することは,長期のCOVID-19予防に不可欠です.
研究 の 目的:
- SARS-CoV-2 感染に対するmRNA ブースターによる第3回の暴露後の体内および細胞免疫反応を比較する.
- ワクチン対ハイブリッド免疫の免疫プロフィールへの影響を調査する.
- T細胞集団の機能的差異を3つの異なる暴露経路で評価する.
主な方法:
- ワクチンの免疫 (mRNAブースター) とハイブリッド免疫 (感染) の比較
- 活体ウイルス中和測定法,IFN-γ ELISpot,Luminex,フローサイトメトリー,および質量サイトメトリーを使用した.
- UCLH-Crick Legacyコホート研究 (NCT04750356) で評価された免疫プロファイル.
主要な成果:
- 3 番目の被曝グループでは,対抗スパイクIgGと変異特異の中和抗体の比喩的なレベルが観察されました.
- T細胞集団は全体的に類似したが,機能的な違いを示した.
- ワクチン群ではCD69とGranzyme Bの CD8+エフェクターメモリ (TEM) 細胞発現が高く,ハイブリッド群では先天性サイトカイン (IL-10, IL-34) とCCL25の発現が高くなった.
結論:
- mRNAブースターと第3の感染は,SARS-CoV-2の変種に対して同様の範囲の保護を提供します.
- 第3の暴露経路は,免疫応答の特定の側面に差異的に影響を与えます.
- 第3の曝露経路に基づく全身および粘膜部位における長期的な免疫を理解するためにさらなる研究が必要である.
関連する概念動画
Vaccinations
45.3K
Overview
45.3K
Immunological Memory
4.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
4.8K
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


